康泰医学（300869）7月30日主力资金净流入7210.99万元

Core Insights - The stock price of Kangtai Medical (300869) closed at 20.48 yuan, reflecting a 9.64% increase as of July 30, 2025 [1] - The company reported a total revenue of 112 million yuan for Q1 2025, representing a year-on-year growth of 12.77% [1] - The net profit attributable to shareholders reached 16.44 million yuan, showing a significant year-on-year increase of 277.67% [1] Financial Performance - The company's net profit after deducting non-recurring items was 13.77 million yuan, with a remarkable year-on-year growth of 515.19% [1] - Current ratio stands at 12.442, and quick ratio at 10.900, indicating strong liquidity [1] - The debt-to-asset ratio is reported at 32.77%, suggesting a moderate level of financial leverage [1] Market Activity - The trading volume was 500,600 lots, with a total transaction value of 1.022 billion yuan [1] - Main capital inflow for the day was 72.11 million yuan, accounting for 7.05% of the total transaction value [1] - Large orders contributed to a net inflow of 33.95 million yuan, while small orders saw a net outflow of 46.66 million yuan [1] Company Background - Kangtai Medical was established in 1996 and is located in Qinhuangdao City, primarily engaged in other manufacturing industries [2] - The company has a registered capital of 401.80 million yuan and a paid-in capital of 360.80 million yuan [1][2] - The legal representative of the company is Hu Kun [1]